154 related articles for article (PubMed ID: 19697973)
1. Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?
Wang L; Angley MT; Gerber JP; Young RL; Abarno DV; McKinnon RA; Sorich MJ
Biomarkers; 2009 Dec; 14(8):596-603. PubMed ID: 19697973
[TBL] [Abstract][Full Text] [Related]
2. Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders.
Bull G; Shattock P; Whiteley P; Anderson R; Groundwater PW; Lough JW; Lees G
Med Sci Monit; 2003 Oct; 9(10):CR422-5. PubMed ID: 14523330
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome?
Wang L; Angley MT; Sorich MJ; Young RL; McKinnon RA; Gerber JP
Autism Res; 2010 Oct; 3(5):268-72. PubMed ID: 20589913
[TBL] [Abstract][Full Text] [Related]
4. Is the presence of urinary indolyl-3-acryloylglycine associated with autism spectrum disorder?
Wright B; Brzozowski AM; Calvert E; Farnworth H; Goodall DM; Holbrook I; Imrie G; Jordan J; Kelly A; Miles J; Smith R; Town J
Dev Med Child Neurol; 2005 Mar; 47(3):190-2. PubMed ID: 15739724
[TBL] [Abstract][Full Text] [Related]
5. Measurement of urine indolylacroylglycine is not useful in the diagnosis or dietary management of autism.
Dalton NR; Chandler S; Turner C; Charman T; Pickles A; Simonoff E; Baird G
Autism Res; 2017 Mar; 10(3):408-413. PubMed ID: 27569540
[TBL] [Abstract][Full Text] [Related]
6. Can urinary indolylacroylglycine levels be used to determine whether children with autism will benefit from dietary intervention?
Wilson J; Wright B; Jost S; Smith R; Pearce H; Richardson S
Pediatr Res; 2017 Apr; 81(4):672-679. PubMed ID: 27879968
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members.
Wang LW; Tancredi DJ; Thomas DW
J Dev Behav Pediatr; 2011 Jun; 32(5):351-60. PubMed ID: 21555957
[TBL] [Abstract][Full Text] [Related]
8. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity.
Nataf R; Skorupka C; Amet L; Lam A; Springbett A; Lathe R
Toxicol Appl Pharmacol; 2006 Jul; 214(2):99-108. PubMed ID: 16782144
[TBL] [Abstract][Full Text] [Related]
9. Variability in outcome for children with an ASD diagnosis at age 2.
Turner LM; Stone WL
J Child Psychol Psychiatry; 2007 Aug; 48(8):793-802. PubMed ID: 17683451
[TBL] [Abstract][Full Text] [Related]
10. A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder.
Kern JK; Geier DA; Adams JB; Geier MR
Biometals; 2010 Dec; 23(6):1043-51. PubMed ID: 20532957
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders.
Jyonouchi H; Geng L; Ruby A; Reddy C; Zimmerman-Bier B
J Pediatr; 2005 May; 146(5):605-10. PubMed ID: 15870662
[TBL] [Abstract][Full Text] [Related]
12. Identification of indolyl-3-acryloylglycine in the urine of people with autism.
Anderson RJ; Bendell DJ; Garnett I; Groundwater PW; Lough WJ; Mills MJ; Savery D; Shattock PE
J Pharm Pharmacol; 2002 Feb; 54(2):295-8. PubMed ID: 11858215
[TBL] [Abstract][Full Text] [Related]
13. Modeling clinical outcome of children with autistic spectrum disorders.
Coplan J; Jawad AF
Pediatrics; 2005 Jul; 116(1):117-22. PubMed ID: 15995041
[TBL] [Abstract][Full Text] [Related]
14. Urinary p-cresol is elevated in small children with severe autism spectrum disorder.
Altieri L; Neri C; Sacco R; Curatolo P; Benvenuto A; Muratori F; Santocchi E; Bravaccio C; Lenti C; Saccani M; Rigardetto R; Gandione M; Urbani A; Persico AM
Biomarkers; 2011 May; 16(3):252-60. PubMed ID: 21329489
[TBL] [Abstract][Full Text] [Related]
15. Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms.
Ashwood P; Wakefield AJ
J Neuroimmunol; 2006 Apr; 173(1-2):126-34. PubMed ID: 16494951
[TBL] [Abstract][Full Text] [Related]
16. Attention deficit/hyperactivity disorder in children and adolescents with autism spectrum disorder: symptom or syndrome?
Sinzig J; Walter D; Doepfner M
J Atten Disord; 2009 Sep; 13(2):117-26. PubMed ID: 19380514
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention.
Jyonouchi H; Geng L; Ruby A; Zimmerman-Bier B
Neuropsychobiology; 2005; 51(2):77-85. PubMed ID: 15741748
[TBL] [Abstract][Full Text] [Related]
18. Are urinary porphyrins a valid diagnostic biomarker of autism spectrum disorder?
Shandley K; Austin DW; Bhowmik JL
Autism Res; 2014 Oct; 7(5):535-42. PubMed ID: 24756868
[TBL] [Abstract][Full Text] [Related]
19. Autism spectrum disorders in young children: effect of changes in diagnostic practices.
Nassar N; Dixon G; Bourke J; Bower C; Glasson E; de Klerk N; Leonard H
Int J Epidemiol; 2009 Oct; 38(5):1245-54. PubMed ID: 19737795
[TBL] [Abstract][Full Text] [Related]
20. Validation of the phenomenon of autistic regression using home videotapes.
Werner E; Dawson G
Arch Gen Psychiatry; 2005 Aug; 62(8):889-95. PubMed ID: 16061766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
